GKHT Medical Technology Co

GKHT Medical Technology Co Debt/EBITDA

The Total Debt to EBITDA Ratio of GKHT Medical Technology Co (301370.SZ) as of Oct 27, 2026 is 0.86. In the previous year, Total Debt to EBITDA Ratio was 0.46 — a change of 87.81% (higher).

Debt/EBITDA

0.86

YoY

87.81%

Last updated:

Total Debt to EBITDA Ratio of GKHT Medical Technology Co is 2025 0.86 . Total Debt to EBITDA Ratio of GKHT Medical Technology Co was 2024 0.46 . It decreases by 87.81% higher compared to the previous year.

The GKHT Medical Technology Co Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2020
6.31 CNY
Jan 1, 2022
0.34 CNY
Jan 1, 2023
0.31 CNY
Jan 1, 2024
0.46 CNY
Jan 1, 2025
0.86 CNY
The GKHT Medical Technology Co Debt/EBITDA history
YEARDebt/EBITDAYoY
0.86+87.81%
0.46+47.91%
0.31-9.57%
0.34-94.55%
6.31—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GKHT Medical Technology Co Stock analysis

What does GKHT Medical Technology Co do? GKHT Medical Technology Co Ltd generates revenue through the distribution and direct sales of medical devices, including vascular interventional therapy materials, orthopedic materials, neurosurgery materials, non-vascular interventional therapy materials, and dental materials. The company provides comprehensive services such as warehousing logistics distribution, distribution channel management, distribution process information management, and hospital supply, sorting, and distribution (SPD) operation management. Its clients include healthcare providers and hospital facilities requiring medical device supply chain solutions. The firm operates within the Health Care Providers & Services industry, focusing on China-based medical device distribution. It serves hospitals and healthcare institutions through its integrated supply chain services, managing logistics, channel distribution, and SPD operations. The company's product portfolio spans multiple medical specialties, supporting diverse clinical needs. GKHT Medical Technology Co Ltd's revenue streams are derived from both product sales and service contracts. The distribution of medical devices and the management of hospital supply chains form the core of its business model. Its services are tailored to meet the operational requirements of healthcare facilities, ensuring efficient delivery and management of medical supplies. GKHT Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GKHT Medical Technology Co stock

Total Debt to EBITDA Ratio of GKHT Medical Technology Co is 0.86 in 2025.

Total Debt to EBITDA Ratio of GKHT Medical Technology Co changed from 0.46 to 0.86, representing a 87.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio GKHT Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's GKHT Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — GKHT Medical Technology Co

All Key Metrics — GKHT Medical Technology Co